cetuximab,rg6330
roche,eli lilly
['rectal', 'gdc-6036', 'colorectal', 'cetuximab']
if you didn't make it to #aacr2023 you can still hear and read prof desai take out messages on the use of a new kras g12c inhibitor, divarasib (gdc-6036) plus cetuximab in colorectal cancer. positive results in this first in human trial led by peter mac. 
Cancer-dedicated research workforce @PeterMacCC. Committed to better treatments, care and cures for cancer